Skip to main content

Meningococcal Polysaccharide Vaccine Dosage

Applies to the following strengths: single dose; multiple dose

Usual Adult Dose for Meningococcal Meningitis Prophylaxis

0.5 mL, subcutaneously, once

Usual Pediatric Dose for Meningococcal Meningitis Prophylaxis

2 years and older:
0.5 mL, subcutaneously, once

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dose Adjustments

  • The ACIP has recommendations for revaccination of high risk patients.
  • If used for revaccination, the dose is 0.5 mL, subcutaneously.


Safety and efficacy have not been established in patients younger than 2 years.

To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at:

Consult WARNINGS section for additional precautions.


Data not available

Other Comments

Administration advice:

  • Do not administer IV or IM.
  • The deltoid region is the preferred administration site.
  • Single dose vials should be used immediately after reconstitution.
  • Multidose vials may be used for up to 35 days after reconstitution if stored at 35 to 46F.

Storage requirements:
  • Refrigerate; do not freeze.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.